Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?


Ayhan M., Turan N., Köstek O., Tufan G., Tataroğlu Ö., Odabas H., ...Daha Fazla

Current problems in cancer, ss.100670, 2020 (SCI Expanded İndekslerine Giren Dergi) identifier identifier